High Dose Rate Brachytherapy(HDR BT) in Organ Confined Prostate Cancer

Ash, 2000, ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer, Radiother Oncol, 57, 315, 10.1016/S0167-8140(00)00306-6 Nag, 1999, American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer, Int J Radiat Oncol Biol Phys, 44, 789, 10.1016/S0360-3016(99)00069-3 Borghede, 1997, Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma, Radiother Oncol, 44, 237, 10.1016/S0167-8140(97)00121-7 Demanes, 2000, High dose rate prostate brachytherapy: The California endocurietherapy (CET) method, Radiother Oncol, 57, 289, 10.1016/S0167-8140(00)00291-7 Yoshioka, 2006, High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer, Radiother Oncol, 80, 62, 10.1016/j.radonc.2006.06.011 Mark, 2005, Interstitial high dose rate (HDR) brachytherapy + IMRT vs. HDR monotherapy for early stage prostate cancer, Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, 23, 4718 Hoskin, P. Bownes, L. Bryant, P Ostler. HDR Monotherapy Brachytherapy for Localised Prostate Cancer. Clinical Oncology, 19 (3), S7-S7 P. High Dose Rate Monotherapy for Prostate Cancer Early Result: D Jeffrey Demanes, M D, Gillian Altieri, C M D David Brandt, M A, Lionel Schour, M D, Marie-Claire Barnaba, MSN-NP, Pat Skoolisariyaporn MS. Presented at American Society for Therapeutic Radiology and Oncology (ASTRO) Conference October 2005. Grills, 2004, High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds, J Urol, 171, 1098, 10.1097/01.ju.0000113299.34404.22